Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0001486 (
Adenovirus
)
3,125
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bone morphogenetic protein (
BMP
)-9 has been reported to regulate energy balance
in vivo
. However, the mechanisms underlying
BMP9
-mediated regulation of energy balance remain incompletely understood. Here, we investigated the role of
BMP9
in energy metabolism. In the current study, we found that hepatic
BMP9
expression was down-regulated in insulin resistance (IR) mice and in patients who are diabetic. In mice fed a high-fat diet (HFD), the overexpression of hepatic
BMP9
improved glucose tolerance and IR. The expression of gluconeogenic genes was down-regulated, whereas the level of insulin signaling molecule phosphorylation was increased in the livers of
Adenovirus
-
BMP9
-treated mice and glucosamine-treated hepatocytes. Furthermore,
BMP9
overexpression ameliorated triglyceride accumulation and inhibited the expression of lipogenic genes in both human hepatocellular carcinoma HepG2 cells treated with a fatty acid mixture as well as the livers of HFD-fed mice. In hepatocytes isolated from sterol regulatory element-binding protein (
SREBP
)-1c knockout mice, the effects of
BMP9
were ablated. Mechanistically,
BMP9
inhibited
SREBP-1c
expression through the inhibition of liver X receptor response element 1 activity in the
SREBP-1c
promoter. Taken together, our results show that
BMP9
is an important regulator of hepatic glucose and lipid metabolism.-Yang, M., Liang, Z., Yang, M., Jia, Y., Yang, G., He, Y., Li, X., Gu, H. F., Zheng, H., Zhu, Z., Li, L. Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism.
...
PMID:Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism. 3123 75